S. Schann et al. / Bioorg. Med. Chem. 20 (2012) 4710–4715
4715
13. Munk, S. A.; Lai, R. K.; Burke, J. E.; Arasasingham, P. N.; Kharlamb, A. B.;
Manlapaz, C. A.; Padillo, E. U.; Wijono, M. K.; Hasson, D. W.; Wheeler, L. A.;
Garst, M. E. J. Med. Chem. 1996, 39, 1193.
14. Schann, S.; Bruban, V.; Pompermayer, K.; Feldman, J.; Pfeiffer, B.; Renard, P.;
Scalbert, E.; Bousquet, P.; Ehrhardt, J.-D. J. Med. Chem. 2001, 44, 1588.
15. Yoro Sy, G.; Urosevic, D.; Fellman, L.; Greney, H.; Bousquet, P.; Feldman, J. J.
Hypertens. 2008, 26, 1025.
16. Crane, L.; Anastassiadou, M.; El Hage, S.; Stigliani, J-L.; Baziard-Mouysset, G.;
Payard, M.; Leger, J-M.; Bizot-Espiard, J. G.; Ktorza, A.; Caignard, D. H.; Renard,
P. Bioorg. Med. Chem. 2006, 14, 7419.
17. Saczewski, F.; Kornicka, A.; Rybczyn´ ska, A.; Hudson, A. L.; Miao, S. S.; Gdaniec,
M.; Boblewski, K.; Lehmann, A. J. Med. Chem. 2008, 51, 3599.
18. Gentili, F.; Cardinaletti, C.; Vesprini, C.; Ghelfi, F.; Farande, A.; Giannella, M.;
Piergentili, A.; Quaglia, W.; Mattioli, L.; Perfumi, M.; Hudson, A.; Pigini, M. J.
Med. Chem. 2008, 51, 5130.
19. Nikolic, K.; Filipic, S.; Agbaba, D. Bioorg. Med. Chem. 2008, 16, 7134.
20. Treder, A. P.; Andruszkiewicz, R.; Zgoda, W.; Ford, C.; Hudson, A. L. Bioorg. Med.
Chem. Lett. 2009, 19, 1009.
21. Kornicka, A.; Hudson, A. L.; Bednarski, P. J. Acta Pol. Pharm. 2009, 66, 523.
22. Jen, T.; van Hoeven, H.; Groves, W.; McLean, R. A.; Loev, B. J. Med. Chem. 1975,
18, 90.
23. Pompermayer, K. Ph.D. Thesis, University of Sao-Paulo, Brazil, 2001.
24. Ernsberger, P.; Damon, T. H.; Graff, L. M.; Schafer, S. G.; Christen, M. O. J.
Pharmacol. Exp. Ther. 1993, 264, 172.
5.4.3. Accreditation
All the methods employed in this work are in accordance with
the French law concerning experimentations on vertebrate labora-
tory animals (Décret 2001-464 from May 29, 2001 as a revision of
the Décret 87-848, 1987) and according to European guidelines.
L.M., J.F. and P.B. hold personal agreements from the Direction
des Services Vétérinaires du Bas-Rhin, Agriculture Ministery,
France (authorisation numbers 67-210 to LM, 67-2010 to JF, 67-
249 to PB) which cover the protocols followed in the present study.
Data are given as mean s.e. mean. Homogeneity of initial car-
diovascular parameters between groups was checked with an
ANOVA.
Acknowledgments
S.S. was supported by a CIFRE grant from the Association Natio-
nale de la Recherche Technique (ANRT) and Institut de Recherches
Internationales Servier (IRIS). We thank IRIS for financial support.
25. Greney, H.; Urosevic, D.; Schann, S.; Dupuy, L.; Bruban, V.; Ehrhardt, J.-D.;
Bousquet, P.; Dontenwill, M. Mol. Pharmacol. 2002, 62, 181.
26. Ehrhardt, J. D. Thérapie 1972, 27, 947.
Supplementary data
27. Malen, C.; Desnos, M.; Laubie, M.; Poignant, J.-C. US Patent 3988,464,
1976.
28. Bredereck, H.; Bredereck, K. Chem. Ber. 1961, 94, 2278.
29. Treder, A. P.; Andruszkiewicz, R.; Zgoba, W.; Walkowiak, A.; Ford, C.; Hudson,
A. L. Bioorg. Med. Chem. 2011, 19, 156.
30. Salminen, T.; Varis, M.; Nyronen, T.; Pihlavisto, M.; Hoffren, A. M.; Lonnberg, T.;
Marjamaki, A.; Frang, H.; Savola, J. M.; Scheinin, M.; Johnson, M. S. J. Biol. Chem.
1999, 274, 23405.
31. Piletz, J. E.; Zhu, H.; Chikkala, D. N. J. Pharmacol. Exp. Ther. 1996, 279, 694.
32. Molderings, G. J.; Moura, D.; Fink, K.; Bönisch, H.; Göthert, M. Naunyn-
Schmiedeberg’s Arch. Pharmacol. 1993, 348, 70.
33. Piletz, J. E.; Sletten, K. J. Pharmacol. Exp. Ther. 1993, 267, 1493.
34. Ernsberger, P.; Haxhiu, M. A.; Graff, L. M.; Collins, L. A.; Dreshaj, I.; Grove, D. L.;
Graves, M. E.; Schafer, S. G.; Christen, M. O. Cardiovasc. Drugs Ther. 1994,
27.
35. Urosevic, D.; Schann, S.; Ehrhardt, J.-D.; Bousquet, P.; Greney, H. Br. J.
Pharmacol. 2004, 142, 609.
Supplementary data associated with this article can be found, in
References and notes
1. Ernsberger, P.; Friedman, J. E.; Koletsky, R. J. J. Hypertens. 1997, 15, S9.
2. Li, G.; Regunathan, S.; Barrow, C. J.; Eshraghi, J.; Cooper, R.; Reis, D. J. Science
1994, 263, 966.
3. Atlas, D.; Burstein, Y. Eur. J. Biochem. 1984, 144, 287.
4. Musgrave, I. F.; Badoer, E. Br. J. Pharmacol. 2000, 129, 1057.
5. Prell, G. D.; Martinelli, G. P.; Holstein, G. R.; Matulic-Adamic, J.; Watanabe, K. A.;
Chan, S. L.; Morgan, S. G.; Haxhiu, M. A.; Ernsberger, P. Proc. Natl. Acad. Sci. U.S.A.
2004, 101, 13677.
6. Separovic, D.; Kester, M.; Ernsberger, P. Mol. Pharmacol. 1996, 49, 668.
7. Greney, H.; Ronde, P.; Magnier, C.; Maranca, F.; Rascente, C.; Quaglia, M.;
Gianella, M.; Pigini, M.; Brasili, L.; Lugnier, C.; Bousquet, P.; Dontenwill, M. Mol.
Pharmacol. 2000, 57, 1142.
36. Sannajust, F.; Cerutti, C.; Koenig-Berard, E.; Sassard, J. Br. J. Pharmacol. 1992,
105, 542.
37. Gentili, F.; Bousquet, P.; Brasili, L.; Caretto, M.; Carrieri, A.; Dontenwill, M.;
Giannella, M.; Marucci, G.; Perfumi, M.; Piergentili, A.; Quaglia, W.; Rascente,
C.; Pigini, M. J. Med. Chem. 2002, 45, 32.
38. Newman-Tancredi, A.; Nicolas, J. P.; Audinot, V.; Gavaudan, S.; Verriele, L.;
Touzard, M.; Chaput, C.; Richard, N.; Millan, N. J. Naunyn-Schmiedeberg’s Arch.
Pharmacol. 1998, 358, 197.
8. Zhang, J. J. Pharmacol. Exp. Ther. 2005, 314, 945.
9. Tesson, F.; Limon-Boulez, I.; Urban, P.; Puype, M.; Vandekerckhove, J.; Coupry,
I.; Pompon, D.; Parini, A. J. Biol. Chem. 1995, 270, 9856.
10. Morgan, N. G.; Chan, S. L. Curr. Pharm. Des. 2001, 14, 1413.
11. Bousquet, P.; Feldman, J. Drugs 1999, 58, 799.
12. Ye, H. F.; Dive, G.; Dehareng, D.; Heymans, F.; Godfroid, J. J. Bioorg. Med. Chem.
2000, 8, 1861.
39. Cheng, Y. C.; Prussof, W. H. Biochem. Pharmacol. 1973, 22, 1839.